We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Guidance following recommendations from the Commission on Human Medicines.
How to apply for an authorisation to manufacture authorised veterinary medicines or medicines marketed under the Exemptions for small pet animals.
Check the veterinary product information database to find out if a medicine is safe to use on your pet or has been removed from sale
Letter about the importance of handling and storing medicines in a safe and secure manner
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes muscle weakness, which can affect multiple muscle groups throughout the...
Industry must notify the MHRA if they will not be using these flexibilities
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
Medicines that were granted a positive opinion under the early access to medicines scheme (EAMS) which has now expired.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Guidance for industry on flexible approaches we are taking on good distribution practices.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
How socioeconomic status and perceptions about medicines availability and affordability influence access
Apply to import a medicine for veterinary use into the UK.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Read about talking therapies and counselling for mental health problems.
The guidance and forms you need to import a human medicine into the UK, including unlicensed medicines.
Biheldon cat and dog wormers seized at East Midlands Airport.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).